Cargando…

Antibody–drug nanoparticle induces synergistic treatment efficacies in HER2 positive breast cancer cells

Chemotherapeutic drugs suffer from non-specific binding, undesired toxicity, and poor blood circulation which contribute to poor therapeutic efficacy. In this study, antibody–drug nanoparticles (ADNs) are engineered by synthesizing pure anti-cancer drug nanorods (NRs) in the core of nanoparticles wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abedin, Muhammad Raisul, Powers, Kaitlyne, Aiardo, Rachel, Barua, Dibbya, Barua, Sutapa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016985/ https://www.ncbi.nlm.nih.gov/pubmed/33795712 http://dx.doi.org/10.1038/s41598-021-86762-6

Ejemplares similares

Isolation and purification of glycoglycerolipids to induce apoptosis in breast cancer cells
por: Abedin, Muhammad Raisul, et al.
Publicado: (2021)

Polymer coated gold-ferric oxide superparamagnetic nanoparticles for theranostic applications
por: Abedin, Muhammad Raisul, et al.
Publicado: (2018)

A multiscale modeling study of particle size effects on the tissue penetration efficacy of drug-delivery nanoparticles
por: Islam, Mohammad Aminul, et al.
Publicado: (2017)

PolyRad – Protection Against Free Radical Damage
por: Kim, Hannah, et al.
Publicado: (2020)

Antibody-drug conjugates in HER2-positive breast cancer
por: Li, Lixi, et al.
Publicado: (2022)

PolyBall: A new adsorbent for the efficient removal of endotoxin from biopharmaceuticals
por: Razdan, Sidharth, et al.
Publicado: (2019)

Heteromer Nanostars by Spontaneous Self-Assembly
por: Brocker, Caitlin, et al.
Publicado: (2017)

Antibody-Drug Conjugates for the Treatment of HER2-Positive Breast Cancer
por: Najjar, Mariana K., et al.
Publicado: (2022)

Advances in Antibody-Drug Conjugates in the Treatment of HER2-Positive Breast Cancer
por: Yu, Yongchao, et al.
Publicado: (2022)

A High Throughput and Unbiased Machine Learning Approach for Classification of Graphene Dispersions
por: Abedin, Md. Joynul, et al.
Publicado: (2020)

An Elaborate New Linker System Significantly Enhances the Efficacy of an HER2‐Antibody‐Drug Conjugate against Refractory HER2‐Positive Cancers
por: Shin, Seol Hwa, et al.
Publicado: (2021)

The Synergistic Effects of Pyrotinib Combined With Adriamycin on HER2-Positive Breast Cancer
por: Wang, Chaokun, et al.
Publicado: (2021)

Multicomponent Conjugates of Anticancer Drugs and Monoclonal Antibody with PAMAM Dendrimers to Increase Efficacy of HER-2 Positive Breast Cancer Therapy
por: Marcinkowska, Monika, et al.
Publicado: (2019)

Predicting efficacy of drug-carrier nanoparticle designs for cancer treatment: a machine learning-based solution
por: Kibria, Md Raisul, et al.
Publicado: (2023)

Antibody–Drug Conjugates (ADC) in HER2/neu-Positive Gynecologic Tumors
por: McNamara, Blair, et al.
Publicado: (2023)

COVID-19 implications for banks: evidence from an emerging economy
por: Barua, Bipasha, et al.
Publicado: (2020)

Modeling the predictors of mobile health adoption by Rohingya Refugees in Bangladesh: An extension of UTAUT2 using combined SEM-Neural network approach
por: Barua, Zapan, et al.
Publicado: (2023)

Preparation and characterization of antibody-drug conjugates acting on HER2-positive cancer cells
por: Chiang, Zu-Chian, et al.
Publicado: (2020)

Synergistic antitumor efficacy against the EGFRvIII(+)HER2(+) breast cancers by combining trastuzumab with anti-EGFRvIII antibody CH12
por: Xu, Wen, et al.
Publicado: (2015)

Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
por: Stanowicka-Grada, Malwina, et al.
Publicado: (2023)

Antibody-drug conjugates with HER2-targeting antibodies from synthetic antibody libraries are highly potent against HER2-positive human gastric tumor in xenograft models
por: Kuo, Wei-Ying, et al.
Publicado: (2018)

Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody–Drug Conjugates in Breast Cancer
por: Duro-Sánchez, Santiago, et al.
Publicado: (2022)

HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates
por: Ocaña, Alberto, et al.
Publicado: (2020)

Implementing antibody-drug conjugates (ADCs) in HER2-positive breast cancer: state of the art and future directions
por: Ferraro, Emanuela, et al.
Publicado: (2021)

The change of paradigm in the treatment of HER2-positive breast cancer with the development of new generation antibody-drug conjugates
por: Escrivá-de-Romaní, Santiago, et al.
Publicado: (2023)

A novel nanobody-based HER2-targeting antibody exhibits potent synergistic antitumor efficacy in trastuzumab-resistant cancer cells
por: Liu, Xinlin, et al.
Publicado: (2023)

Development of a Novel Design and Subsequent Fabrication of an Automated Touchless Hand Sanitizer Dispenser to Reduce the Spread of Contagious Diseases
por: Das, Arnab, et al.
Publicado: (2021)

Synergistic Targeting HER2 and EGFR with Bivalent Aptamer-siRNA Chimera Efficiently Inhibits HER2-Positive Tumor Growth
por: Xue, Lu, et al.
Publicado: (2018)

A combination of trastuzumab and BAG-1 inhibition synergistically targets HER2 positive breast cancer cells
por: Papadakis, Emmanouil, et al.
Publicado: (2016)

Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells
por: Vanderhoeven, Fiorella, et al.
Publicado: (2018)

A Novel Homodimer Peptide–Drug Conjugate Improves the Efficacy of HER2-Positive Breast Cancer Therapy
por: Liu, Shurong, et al.
Publicado: (2023)

Synergistic Effects of Metformin and Trastuzumab on HER2 Positive Gastroesophageal Adenocarcinoma Cells In Vitro and In Vivo
por: Kim, Jin-Soo, et al.
Publicado: (2023)

Dynamics of Endocytosis and Degradation of Antibody-Drug Conjugate T-DM1 in HER2 Positive Cancer Cells
por: Liang, Keying, et al.
Publicado: (2021)

Novel Anti-HER2 Antibody-Drug Conjugates Versus T-DM1 for HER2-Positive Metastatic Breast Cancer After Tyrosine Kinase Inhibitors Treatment
por: Ji, Chenchen, et al.
Publicado: (2023)

The Curious Case of an Elusive Solitary Plaque
por: Katoch, Saloni, et al.
Publicado: (2020)

Role of Botulinum Toxin in the Management of Topical Corticosteroid Induced Rosacea Like Dermatitis: A Case Report
por: Katoch, Saloni, et al.
Publicado: (2022)

Engineering a HER2-specific antibody-drug conjugate to increase lysosomal delivery and therapeutic efficacy
por: Kang, Jeffrey C., et al.
Publicado: (2019)

Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer
por: Schneeweiss, Andreas, et al.
Publicado: (2018)

HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies
por: Gandullo‐Sánchez, Lucía, et al.
Publicado: (2020)

Simultaneous Discovery of Positive and Negative Interactions Among Rhizosphere Bacteria Using Microwell Recovery Arrays
por: Barua, Niloy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_635463k8784c3olpq667ud68hp